Revista de gastroenterologia de Mexico (English)最新文献

Masson's pseudoangiosarcoma located in the perianal region: A rare entity. 位于肛周的马森氏假性血管肉瘤：罕见病例。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-13 DOI: 10.1016/j.rgmxen.2024.09.010

G R Medina-Murillo, U Rodríguez-Medina, U Rodríguez-Wong

引用次数: 0

Cannabinoid hyperemesis syndrome: A review. 大麻素呕吐综合征：综述。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-13 DOI: 10.1016/j.rgmxen.2025.02.002

R A Jiménez-Castillo, S Arumugam, J M Remes-Troche, T Venkatesan

{"title":"Cannabinoid hyperemesis syndrome: A review.","authors":"R A Jiménez-Castillo, S Arumugam, J M Remes-Troche, T Venkatesan","doi":"10.1016/j.rgmxen.2025.02.002","DOIUrl":"https://doi.org/10.1016/j.rgmxen.2025.02.002","url":null,"abstract":"Cannabinoid hyperemesis syndrome (CHS) is a chronic disorder characterized by episodes of severe vomiting, alternating with asymptomatic or minimally symptomatic periods. The episodes of emesis tend to be disabling, negatively affecting quality of life. The disorder's main characteristic is that it is associated with previous chronic heavy cannabis use. CHS is similar to cyclic vomiting syndrome (CVS), with the exception that the sustained cessation of cannabis use is expected to resolve the vomiting episodes. The average time between the onset of acute CHS episodes and diagnosis ranges from three to six years, based on previously published cases. This delay in the diagnosis reflects a lack of awareness of the condition on the part of physicians. Delayed diagnosis of CHS results in frequent emergency room visits and increased healthcare costs, and the lack of effective treatment leads to poor patient outcomes. The diagnosis is challenging, and some authors have diagnosed CHS when patients had cyclic vomiting, in the context of chronic cannabis use, regardless of the duration of use or the potency of the product used. The aim of this narrative review is to provide a detailed and critical analysis of current knowledge about CHS. The present document focuses on a thorough review of the literature on worldwide cannabis use, the role of the endocannabinoid system in the pathophysiology of CHS, diagnostic criteria, and current management of CHS.","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144295460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Response to Crespo et al., regarding 'Preoperative management of patients receiving treatment with GLP-1 analogues: Withhold or individualize?' 对Crespo等人关于“接受GLP-1类似物治疗的患者的术前管理：保留或个体化？”

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-10 DOI: 10.1016/j.rgmxen.2024.12.004

J A Velarde-Ruiz Velasco, J R Barrientos-Ávalos, E C Morel-Cerda

引用次数: 0

Good clinical practice recommendations for the management of gastroesophageal reflux disease. A Latin American expert review. 胃食管反流病管理的良好临床规范建议。拉丁美洲专家审查。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-10 DOI: 10.1016/j.rgmxen.2025.02.001

M A Valdovinos-Díaz, A Hani, C Defilippi-Guerra, L Fernando-Pineda, J M Remes-Troche, A Riquelme, L J Abrahão-Junior, L Aguilar-Paiz, C Almonte-Nuñez, H Burgos, C Días, O Gómez-Escudero, I Hanna-Jairala, C Olano, J A Olmos, A Ortiz, G Otoya, J L Tamayo-de la Cuesta, J Suazo-Barahona, E Vesco-Monteagudo, L R Valdovinos-García, J S Arenas-Martínez

{"title":"Good clinical practice recommendations for the management of gastroesophageal reflux disease. A Latin American expert review.","authors":"M A Valdovinos-Díaz, A Hani, C Defilippi-Guerra, L Fernando-Pineda, J M Remes-Troche, A Riquelme, L J Abrahão-Junior, L Aguilar-Paiz, C Almonte-Nuñez, H Burgos, C Días, O Gómez-Escudero, I Hanna-Jairala, C Olano, J A Olmos, A Ortiz, G Otoya, J L Tamayo-de la Cuesta, J Suazo-Barahona, E Vesco-Monteagudo, L R Valdovinos-García, J S Arenas-Martínez","doi":"10.1016/j.rgmxen.2025.02.001","DOIUrl":"https://doi.org/10.1016/j.rgmxen.2025.02.001","url":null,"abstract":"Introduction and aim: Due to its elevated prevalence, complex pathophysiology, and broad spectrum of clinical manifestations, gastroesophageal reflux disease (GERD) requires precision diagnosis and treatment. The aim of this Latin American expert review was to provide good clinical practice recommendations for the rational use of diagnostic tests and the personalized treatment of GERD.Methods: Good clinical practice recommendations were developed by a group of Latin American experts in GERD. A thorough review of the literature was conducted, and recommendations on the diagnosis and treatment of GERD were issued after three group discussions.Results: Twenty-one experts on GERD formulated 30 clinical recommendations for appropriately indicating diagnostic tests for disease phenotypes and their medical treatment, refractory GERD management, endoscopic and surgical treatment indications, the control of GERD in obesity, pregnancy, and older adults, as well as the role of Helicobacter pylori infection and GLP-1 agonists.Conclusions: Determining GERD phenotypes in patients through the appropriate use of diagnostic tests enables personalized treatment to be prescribed. The recommendations established in this document may contribute to improving the quality of care of patients with GERD.","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Schwann cell hamartoma associated with hyperplastic colon polyp: An exceptional finding. 伴有增生性结肠息肉的雪旺细胞错构瘤：一个罕见的发现。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-10 DOI: 10.1016/j.rgmxen.2024.10.014

G Castillo-López, S González-Vázquez, T Iscar-Galán, L Alarcón-García, J M Riesco-López

引用次数: 0

Preoperative management of patients receiving treatment with GLP-1 analogues: Withhold or individualize? 接受GLP-1类似物治疗的患者的术前管理：保留还是个体化？

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-10 DOI: 10.1016/j.rgmxen.2024.11.007

J Crespo, P Iruzubieta

引用次数: 0

Response to Hinpetch Daungsupawong et al. regarding "Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown: Correspondence". 对Hinpetch Daungsupawong等人关于“在COVID-19大流行封锁期间实施的体重变化和生活方式改变：通信”的回应。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-10 DOI: 10.1016/j.rgmxen.2025.01.004

F Higuera-de-la-Tijera, F Lajud-Barquín, A Tovar-Aguilar

引用次数: 0

C-reactive protein as a predictor of complicated acute cholecystitis: A cohort study. c反应蛋白作为复杂急性胆囊炎的预测因子：一项队列研究。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-09 DOI: 10.1016/j.rgmxen.2025.02.004

G Renau, D Abelló, F Sabench, J Doménech, A Sánchez

{"title":"C-reactive protein as a predictor of complicated acute cholecystitis: A cohort study.","authors":"G Renau, D Abelló, F Sabench, J Doménech, A Sánchez","doi":"10.1016/j.rgmxen.2025.02.004","DOIUrl":"https://doi.org/10.1016/j.rgmxen.2025.02.004","url":null,"abstract":"Introduction: The Tokyo Guidelines for the severity classification of acute cholecystitis (AC) include leukocytosis as a severity classifier, without considering C-reactive protein (CRP). Our aim was to determine which of the two variables has a greater predictive capacity for local complications in AC (LCAC).Material and methods: A retrospective single-center study was conducted on patients that underwent emergency cholecystectomy within the time frame of June 2022 and December 2023. The variables associated with LCAC were analyzed and an ROC analysis was carried out.Results: The multivariate analysis of 145 patients identified the following associations with LCAC: CRP (p < 0.001; OR 11.8), AUC of 0.88 (p = 0.029), and cutoff point of 4 mg/dl (88% sensitivity, 71% specificity); leukocytosis (p < 0.031; OR 5), AUC of 0.81(p = 0.037), and cutoff point of 11.09 x 109/l (78% sensitivity, 70% specificity).Conclusions: CRP may have a higher predictive capacity for LCAC than leukocytosis.","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Commentary on "First Mexican consensus on Crohn's disease" from the pathologist's perspective. 从病理学角度评论“关于克罗恩病的第一次墨西哥共识”。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-09 DOI: 10.1016/j.rgmxen.2024.10.013

J A Teco-Cortes

引用次数: 0

Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown: Correspondence. 在COVID-19大流行封锁期间实施的体重变化和生活方式改变：通信。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-06-09 DOI: 10.1016/j.rgmxen.2024.10.012

H Daungsupawong, V Wiwanitkit

引用次数: 0